Benitec Biopharma
BNTC
BNTC
25 hedge funds and large institutions have $127M invested in Benitec Biopharma in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$65.6M | |
| 2 | +$600K | |
| 3 | +$551K | |
| 4 |
LPC
Lion Point Capital
New York
|
+$358K |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$274K |
Top Sellers
| 1 | -$223K | |
| 2 | -$39.3K | |
| 3 | -$30.3K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.08K |